Morgan Stanley
DXTR

Morgan Stanley’s Dextera Surgical Inc. DXTR Stock Holding History

Morgan Stanley’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-237
Closed – – 6815
2017
Q3 		$0 Sell
237
-15
-6% -$4 ﹤0.01% 6712
2017
Q2 		$0 Buy
252
+15
+6% +$8 ﹤0.01% 6744
2017
Q1 		$0 Hold
237
– – ﹤0.01% 6686
2016
Q4 		$0 Hold
237
– – ﹤0.01% 6629
2016
Q3 		$0 Hold
237
– – ﹤0.01% 6627
2016
Q2 		$0 Buy
+237
New +$486 ﹤0.01% 6803

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Morgan Stanley's DXTR Position: Q4 2017 in Review

Morgan Stanley sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 237 shares.

Morgan Stanley first reported a position in DXTR in Q2 2016 and held it in 6 quarters. The position peaked at $0 in Q3 2017. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • Morgan Stanley reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • Morgan Stanley sold 237 Dextera Surgical Inc. shares in Q4 2017.
  • Morgan Stanley first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 6 quarters.
  • Morgan Stanley's Dextera Surgical Inc. position peaked at $0 in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.